Skip to main content
. Author manuscript; available in PMC: 2023 Aug 5.
Published in final edited form as: J Heart Lung Transplant. 2022 Jul 21;41(11):1628–1637. doi: 10.1016/j.healun.2022.07.015

Table 5.

Reasons for textbook outcome (TO) failure stratified by planned use of venoarterial extracorporeal membrane oxygenation (VA ECMO) support.

Reasons for TO failure Planned Off-pump
N = 169
Planned VA ECMO
N = 68
Total
N = 237
Intraoperative complication 6 (3.6%) 3 (4.4%) 9 (3.8%)
Reintervention within 30 days 32 (18.9%) 22 (32.4%) 54 (22.8%)
Surgical 27 (16.0%) 20 (29.4%) 47 (19.8%)
Re-exploration for bleedinga 17 (63.0%) 15 (75.0%) 32 (68.1%)
Re-exploration for infectiona 2 (7.4%) 1 (5.0%) 3 (6.4%)
Pleural effusion evacuationa 4 (14.8%) 2 (10.0%) 6 (12.8%)
Othera 4 (14.8%) 2 (10.0%) 6 (12.8%)
Bronchoscopic 0 (0.0%) 0 (0.0%) 0 (0.0%)
Radiologic 6 (3.6%) 4 (5.9%) 10 (4.2%)
Intensive care unit readmission within 30 days 29 (17.2%) 13 (19.1%) 42 (17.7%)
Hospital readmission within 30 days 50 (29.6%) 13 (19.1%) 63 (26.6%)
Post-transplant length of stay >30 days 56 (33.1%) 30 (44.1%) 86 (36.3%)
Mortality within 90 days 2 (1.2%) 4 (5.9%) 6 (2.5%)
Acute rejection within 30 days 19 (11.2%) 1 (1.5%) 20 (8.4%)
Grade 3 primary graft dysfunction at 48 or 72 hours 28 (16.6%) 8 (11.8%) 36 (15.2%)
ECMO within 72 hours post-transplant 21 (12.4%) 14 (20.6%) 35 (14.8%)
Timing of post-transplant ECMO initiation b
Cannulated in the operating room prior to transfer to the intensive care unit 20 (95.2%) 14 (100%) 34 (97.1%)
Postoperative day 1 0 (0.0%) 0 (0.0%) 0 (0.0%)
Postoperative day 2 0 (0.0%) 0 (0.0%) 0 (0.0%)
Postoperative day 3 1 (4.8%) 0 (0.0%) 1 (2.9%)
Post-transplant ECMO mode
None 146 (86.4%) 54 (79.4%) 200 (84.4%)
VA 2 (1.2%) 0 (0.0%) 2 (0.8%)
VV 21 (12.4%) 14 (20.6%) 35 (14.8%)
Renal replacement therapy during the index hospitalization 16 (9.5%) 6 (8.8%) 22 (9.3%)
Tracheostomy within 7 days 27 (16.0%) 9 (13.2%) 36 (15.2%)
Reintubation during the index hospitalization 38 (22.5%) 14 (20.6%) 52 (21.9%)
Extubation >48 hours post-transplant 104 (61.5%) 27 (39.7%) 131 (55.3%)

ECMO, extracorporeal membrane oxygenation. TO, textbook outcome. VA, venoarterial. VV, venovenous.

a

Among patients who underwent surgical reintervention within 30 days.

b

Among patients who required ECMO within 72 hours post-transplant.